| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... The Lancet 385 (9986), 2465-2476, 2015 | 1433 | 2015 |
| Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ... European heart journal 41 (22), 2083-2088, 2020 | 1052 | 2020 |
| Effect of platelet inhibition with cangrelor during PCI on ischemic events DL Bhatt, GW Stone, KW Mahaffey, CM Gibson, PG Steg, CW Hamm, ... New England Journal of Medicine 368 (14), 1303-1313, 2013 | 924 | 2013 |
| Thrombin-receptor antagonist vorapaxar in acute coronary syndromes P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ... New England Journal of Medicine 366 (1), 20-33, 2012 | 914 | 2012 |
| Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice C Napolitano, SG Priori, PJ Schwartz, R Bloise, E Ronchetti, J Nastoli, ... Jama 294 (23), 2975-2980, 2005 | 567 | 2005 |
| American heart association council on E, prevention statistics c, stroke statistics s. heart disease and stroke statistics-2019 update: a report from the American heart association EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Circulation 139 (10), e56-e528, 2019 | 512 | 2019 |
| Bivalirudin or unfractionated heparin in acute coronary syndromes M Valgimigli, E Frigoli, S Leonardi, M Rothenbühler, A Gagnor, P Calabrò, ... New England Journal of Medicine 373 (11), 997-1009, 2015 | 416 | 2015 |
| Dual antiplatelet therapy after PCI in patients at high bleeding risk M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni, P Vranckx, Y Ozaki, ... New England Journal of Medicine 385 (18), 1643-1655, 2021 | 376 | 2021 |
| Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data PG Steg, DL Bhatt, CW Hamm, GW Stone, CM Gibson, KW Mahaffey, ... The Lancet 382 (9909), 1981-1992, 2013 | 362 | 2013 |
| Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a … G Crimi, S Pica, C Raineri, E Bramucci, GM De Ferrari, C Klersy, M Ferlini, ... JACC: Cardiovascular Interventions 6 (10), 1055-1063, 2013 | 288 | 2013 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 286 | 2018 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 270 | 2019 |
| Digoxin and mortality in patients with atrial fibrillation RD Lopes, R Rordorf, GM De Ferrari, S Leonardi, L Thomas, DM Wojdyla, ... Journal of the American College of Cardiology 71 (10), 1063-1074, 2018 | 233 | 2018 |
| Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets F D'Ascenzo, O De Filippo, G Gallone, G Mittone, MA Deriu, ... The Lancet 397 (10270), 199-207, 2021 | 230 | 2021 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 203 | 2019 |
| Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study CM Lombardi, V Carubelli, A Iorio, RM Inciardi, A Bellasi, C Canale, ... JAMA cardiology 5 (11), 1274-1280, 2020 | 186 | 2020 |
| Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis E Ammirati, L Lupi, M Palazzini, NS Hendren, JL Grodin, CV Cannistraci, ... Circulation 145 (15), 1123-1139, 2022 | 181 | 2022 |
| Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX G Andò, B Cortese, F Russo, M Rothenbühler, E Frigoli, G Gargiulo, ... Journal of the American College of Cardiology 69 (21), 2592-2603, 2017 | 156 | 2017 |
| Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting A Franzone, E McFadden, S Leonardi, R Piccolo, P Vranckx, PW Serruys, ... Journal of the American College of Cardiology 74 (18), 2223-2234, 2019 | 139 | 2019 |
| Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study D Tomasoni, RM Inciardi, CM Lombardi, C Tedino, P Agostoni, P Ameri, ... European journal of heart failure 22 (12), 2238-2247, 2020 | 136 | 2020 |
